CVC, the private equity fund, is reportedly assessing approaches from several brewers for Starbev, the Czech-based brewer, which has a portfolio of more than 20 brands, including Staropramen. According to the Financial Times, CVC is working with adviser Nomura to look at the approaches for the company, which it acquired for $3bn in December 2009 from Anheuser-Busch InBev. It is not officially up for sale as yet, but it is thought that Starbev would attract interest from Anheuser-Busch InBev, which has the right of first offer to re-acquire the business, and SABMiller.